Levetown & Jenkins, LLP Announces an Investigation of the Acquisition of Clarient, Inc. by GE Healthcare, a unit of General E...
22 Ottobre 2010 - 5:17PM
Business Wire
Levetown & Jenkins, LLP is conducting an investigation into
alleged breaches of fiduciary duties and violations of state law by
Clarient, Inc. (“Clarient”) (NASDAQ: CLRT) and its Board of
Directors in conjunction with the proposed buyout and acquisition
of Clarient by GE Healthcare, a unit of General Electric Company
(NYSE: GE). Under the terms of a definitive merger agreement
announced on October 22, 2010, Clarient shareholders will receive a
tender offer for all outstanding common and preferred shares of
Clarient at $5.00 per common share and $20.00 per preferred share,
payable in cash. The transaction is valued at approximately $580
million, net of cash and investments as of June 30, 2010.
The firm’s investigation concerns whether the proposed
acquisition properly values Clarient. Specifically, the
investigation seeks to determine whether the Clarient Board of
Directors engaged in a fair process to obtain adequate
consideration for all of the company's shareholders, whether the
transaction undervalues the company to the detriment of its
shareholders and, if so, the extent to which the company is
undervalued in the proposed transaction.
Levetown & Jenkins, LLP is a national law firm comprised of
former federal and state prosecutors with extensive experience in
the investigation and prosecution of shareholder fraud. The firm
specializes in the representation of investors in shareholder and
securities fraud class actions. If you currently own shares of
Clarient and wish to obtain additional information about your
rights as a shareholder, please contact Michael T. Harrison, Esq.
at (713) 392-7465 or mharrison@levjen.com. For more information
about the firm, please visit www.levjen.com.
Attorney Advertising. (C) 2010 Levetown & Jenkins, LLP. The
law firm responsible for this advertisement is Levetown &
Jenkins, LLP (www.levjen.com). Prior results do not guarantee or
predict a similar outcome with respect to any future matter. We are
happy to discuss your particular case.
Grafico Azioni Clarient, Inc. (MM) (NASDAQ:CLRT)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Clarient, Inc. (MM) (NASDAQ:CLRT)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a Clarient, Inc. (MM) (NASDAQ): 0 articoli recenti
Più Levetown & Jenkins, LLP Articoli Notizie